Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NeuMoDx Molecular Systems

https://www.neumodx.com/

Latest From NeuMoDx Molecular Systems

Roche Launches COVID-19 Test For Cobas System; BioMérieux Plans Three COVID-19 Tests

Roche announced that the US FDA has granted an Emergency Use Authorization for the cobas SARS-CoV-2 test for patients suspected to have COVID-19. bioMérieux is planning three COVID-19 tests.

Coronavirus COVID-19 Infectious Diseases

Qiagen Secures US HHS Funding For New COVID-19 Test

Qiagen has secured funding from a US government agency to develop a new test kit for COVID-19.

Coronavirus COVID-19 Infectious Diseases

Mayo Clinic Launches COVID-19 Test; Results Within 24 Hours

Mayo Clinic is developing a test to detect COVID-19 in the US.

Coronavirus COVID-19 Infectious Diseases

NeuMoDx Molecular Launches Coronavirus Test

NeuMoDx Molecular announced plans to develop a coronavirus test for its own high-throughput molecular diagnostics platform.

Coronavirus COVID-19 Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
UsernamePublicRestriction

Register